摘要:
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an IL-13 inhibitor. An embodiment of the disclosure relates to releasing the IL- 13 inhibitor at a location in the gastrointestinal tract of a subject that is proximate to one or more sites of disease, by administering an orally ingestible delivery device comprising such IL-13 inhibitor, said device comprise of an ingestible housing comprising a reservoir that contains the IL- 13 inhibitor, a detector coupled to the ingestible housing, a valve system in fluid communication with the reservoir, and a controller communicably coupled to the valve and the detector.
摘要:
Systems and methods for extracting and/or analyzing a sample, such as a sample present in an ingestible device, are disclosed. Methods for extracting a sample from an ingestible device via centrigugation. Sleeve device and adapter device configured to extract the samples from the ingestible device. Grating device to remove a portion of the housing of said ingestible device
摘要:
An implantable medical device, such as a sensor for monitoring a selected internally detectable physiological parameter of a patient, is attached to a fixation assembly that is deployable within the patient to position and orient the sensor to enable it to perform its function. The fixation assembly is formed having at least one flexible asymmetric connector where each fixation member includes a plurality of loops, wherein a first loop of the plurality of loops has a maximum pitch that is different from a maximum pitch of a second loop of the plurality of loops. The attachment of the housing and the fixation assembly includes providing a tubular member that is welded to the housing and crimped over a section of the fixation assembly.
摘要:
A data acquisition device includes measuring instruments to generate physiological and/or psychological data streams. Microprocessors within the acquisition device process the generated data streams into metrics, which feed into stress function algorithms. Algorithm processing may occur either on the device, or metrics may be communicated via wireless communication for external processing on mobile devices and/or cloud-based platforms. The calculated stress functions inform cloud-based computational systems biology-derived models describing the dynamics of hormones and neurotransmitters released in the body in response to stressful stimuli. Stress hormone levels are quantified using these models, and are used in combination to serve as biologically inspired metrics of acute and chronic stress an individual is experiencing.
摘要:
Embodiments herein include implantable medical systems, devices and methods including chemical sensors. In an embodiment, an implantable medical device system includes a chemical sensor; a fluid state sensor such as a posture sensor; an activity sensor; and/or a respiration sensor. The implantable medical device system can further include normalization circuitry receiving data from the chemical sensor and the fluid state sensor and normalizing the chemical sensor data based on data from the fluid state sensor. In an embodiment, a method of operating an implantable medical device system is included. The method can include measuring the amount of a chemical analyte using a chemical sensor, measuring the fluid status in a patient using a fluid state sensor, and normalizing the measured amount of the chemical analyte as indicated by the chemical sensor using normalization circuitry based on data from the fluid state sensor. Other embodiments are also included herein.
摘要:
Dispositif (1), adapté pour être ingéré par un patient, comprenant une matrice (12) à délitement au niveau d'un segment digestif et une pluralité de marqueurs RFID (11) passifs, indépendants et logés ensemble dans la matrice (12) à délitement, la matrice (12) à délitement étant conformée pour qu'une fois délitée, les marqueurs RFID (11) soient séparés les uns des autres et ne soient plus mécaniquement connectés, de sorte que chaque marqueur RFID (11) puisse être déplacé indépendamment des autres marqueurs RFID (11) dans plusieurs segments du système digestif du patient,les marqueurs RFID (11) présentant chacun, dans la matrice (12) à délitement, une protection hermétique par encapsulation dans un matériau biocompatible.
摘要:
A system including a sensor and a transceiver and configured to determine a concentration of an analyte in a medium of a living animal. The sensor may include first and second signal photodetectors and first and second reference photodetectors, which may each be covered by an associate filter. The first photodetector may receive light emitted from first and second grafts, respectively. The grafts may receive excitation light from one or more light sources. The transceiver may receive signals from the photodetectors of the sensor and may determine the analyte concentration based on the received signals.
摘要:
A computer-implemented method is disclosed. The computer-implemented method comprises receiving, by a computer system, ingestible event marker (IEM) system information from a receiver worn by a subject, the IEM system information comprising information associated with ingestion of medication by the subject, wherein the receiver is configured to communicate with the computer system; receiving, by the computer system, contextual information associated with the subject; and calculating, by the computer system, a composite risk score based on the IEM system information and the contextual information associated with the subject.